Stem cell measurement carried out on the Sysmex XN-20 module provides a significant correlation with flow cytometry and might be implemented in clinical practice. In clinical decision-making, there was discrepancy of under 15% of cases. In multiple myeloma patients, XN-20 should be used with caution.
Keyphrases
- peripheral blood
- flow cytometry
- stem cells
- end stage renal disease
- clinical practice
- decision making
- multiple myeloma
- newly diagnosed
- chronic kidney disease
- ejection fraction
- prognostic factors
- bone marrow
- single cell
- machine learning
- cell therapy
- deep learning
- mesenchymal stem cells
- patient reported outcomes
- patient reported
- nk cells